Chart calendar GSK plc

f95e6ad815146cc.js4wEMzkkpkiu4hf2l91447iBkPQ_7D0qTdTsZarqq8.3_17fvuow_RUg9I2qRwxoqOaXCaZh8i54XwY5e7-nd3RjWgiotLoz2PXwQ~dcebbe62660f5d8ef5000a74a248f89e

Upcoming events on GSK plc

31/07/2024 07:00 Q2 2024 Earnings Release
31/07/2024 12:00 Q2 2024 Earnings Call
30/10/2024 06:00 Q3 2024 Earnings Release
05/02/2025 07:00 Q4 2024 Earnings Release
29/04/2025 Q1 2025 Earnings Release (Projected)
22/07/2025 Q2 2025 Earnings Release (Projected)
28/10/2025 Q3 2025 Earnings Release (Projected)
10/02/2026 Q4 2025 Earnings Release (Projected)

Past events on GSK plc

17/06/2024 13:00 Analyst Meeting - Getting Ahead of Cancer
05/06/2024 BNP Paribas Exane CEO Conference
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #8627
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #LBA3512
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #8017
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7530
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #TPS5627
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19523
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #TPS6125
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19532
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19524
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19507
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e19503
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7559
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #e23110
30/05/2024 American Society of Clinical Oncology Meeting - MV. Mateos
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7503
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #7543
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #5606
30/05/2024 American Society of Clinical Oncology Meeting - Abstract No - #5607

Past dividends on GSK plc

15/05/2024 Interim Payment 0.15 GBP
21/02/2024 Final Payment 0.16 GBP
15/11/2023 Interim Payment 0.14 GBP
16/08/2023 Interim Payment 0.14 GBP
17/05/2023 Interim Payment 0.14 GBP
22/02/2023 Final Payment 0.1375 GBP
16/11/2022 Interim Payment 0.1375 GBP
17/08/2022 Interim Payment 0.1625 GBP
18/05/2022 Interim Payment 0.14 GBP
23/02/2022 Final Payment 0.23 GBP
17/11/2021 Interim Payment 0.19 GBP
18/08/2021 Interim Payment 0.19 GBP
19/05/2021 Interim Payment 0.19 GBP
17/02/2021 Final Payment 0.23 GBP
11/11/2020 Interim Payment 0.19 GBP
12/08/2020 Interim Payment 0.19 GBP
13/05/2020 Interim Payment 0.19 GBP
19/02/2020 Final Payment 0.23 GBP
13/11/2019 Interim Payment 0.19 GBP

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million GBP
Released
Forecast
Spread
34 114
34 029
0.25%
29 324
29 105
0.75%
30 328
29 850
1.6%

31 470


33 387


35 302

EBITDA
Million GBP
Released
Forecast
Spread
11 330
10 048
12.76%
10 449
9 257
12.88%
11 635
10 203
14.04%

10 608


11 644


12 613

EBIT
Million GBP
Released
Forecast
Spread
8 806
8 717
1.02%
8 151
7 952
2.5%
8 786
8 780
0.07%

9 148


10 079


11 102

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
5 442
5 794
-6.07%
5 628
5 548
1.45%
6 064
7 498
-19.12%

7 329


8 693


9 644

Net income
Million GBP
Released
Forecast
Spread
4 385
3 990
9.91%
14 956
6 238
139.74%
4 928
5 481
-10.09%

5 489


6 454


7 145

EPS
GBP
Released
Forecast
Spread
1,08
1,02
6.28%
3,66
1,66
120.52%
1,22
1,38
-11.61%

1,33


1,57


1,74

Announcement Date09/02/2201/02/2331/01/24-

Quarterly results

Fiscal PeriodMarch 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million GBP
Released
Forecast
Spread
6 929
6 906
0.33%
7 829
7 214
8.52%
7 376
7 101
3.88%
6 951
6 580
5.64%
7 178
6 795
5.63%
8 147
7 727
5.43%
8 052
7 621
5.65%
7 363
7 060
4.3%

7 505


8 455


7 992


7 530


7 810


8 800


8 545

EBITDA
Million GBP
Released
Forecast
Spread
2 639
2 138
23.45%
3 561
2 704
31.68%
1 602
1 855
-13.63%
2 732
2 418
12.97%
2 622
2 506
4.64%
3 351
3 072
9.09%
2 930
2 094
39.93%
2 992
2 406
24.36%

2 510


3 117


1 784













EBIT
Million GBP
Released
Forecast
Spread
2 008
1 740
15.4%
2 605
2 264
15.08%
1 595
1 509
5.7%
2 092
1 930
8.42%
2 170
1 999
8.56%
2 772
2 570
7.88%
1 752
1 836
-4.58%
2 443
2 099
16.38%

2 207


2 775


1 637


2 498


2 434


3 024


1 993

Earnings before Tax (EBT)
Million GBP
Released
Forecast
Spread
896
1 243
-27.89%
1 012
1 860
-45.59%
1 626
946
71.97%
1 907
1 529
24.72%
1 987
1 500
32.51%
1 791
2 225
-19.51%
379
1 361
-72.15%
1 355
1 696
-20.11%

1 818


2 462


1 241













Net income
Million GBP
Released
Forecast
Spread
975
802
21.54%
10 315
1 356
660.76%
1 495
1 151
29.9%
1 490
1 179
26.41%
1 624
1 213
33.86%
1 464
1 739
-15.79%
350
834
-58.04%
1 046
1 297
-19.32%

1 378


1 881


1 163













EPS
GBP
Released
Forecast
Spread
0,21
0,21
-3.22%
2,52
0,34
640.73%
0,37
0,19
95.19%
0,37
0,29
27.52%
0,40
0,30
35.52%
0,36
0,43
-15.26%
0,09
0,20
-58.02%
0,25
0,31
-19.17%

0,33


0,46


0,21













Announcement Date27/07/2202/11/2201/02/2326/04/2326/07/2301/11/2331/01/2401/05/24-------

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise